Search

MIRATI THERAPEUTICS PRESENTS UPDATED POSITIVE CLINICAL DATA FROM SITRAVATINIB IMMUNO-ONCOLOGY COMBINATION TRIAL AT ESMO 2018 CONGRESS AND ANNOUNCES FDA GUIDANCE FOR REGISTRATION TRIAL

Updated analysis from ongoing Phase 2 trial of sitravatinib in combination with nivolumab demonstrated significant clinical activity...

 
 
 
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

Lessons from “View from the Board: Responding to an Acquisition Offer”

LESSONS FROM “VIEW FROM THE BOARD: RESPONDING TO AN ACQUISITION OFFER”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO Investor Forum focused on real world scenarios...

 
 
 
 
 
 

SR. PHARMACEUTICAL/BIOTECH AUTOMATION ENGINEER - BANKS INTEGRATION GROUP - OCEANSIDE, CA

Independently provide project and facility support activities such as detailed design, design review, implementation, program changes,...

Alnylam Won't Seek Quick FDA Nod For Second RNAi Drug

ALNYLAM WON'T SEEK QUICK FDA NOD FOR SECOND RNAI DRUG

A few weeks ago, Alnylam Pharmaceuticals indicated it might seek a speedy FDA approval for what could be the second-ever RNA interference...

 
 
 

FDA LIFTS CLINICAL HOLD; GREEN-LIGHTS VERTEX AND CRISPR'S SICKLE CELL GENE THERAPY TRIAL

Posted on: 14 October 2018, The U.S. Food and Drug Administration has lifted a clinical hold and accepted an Investigational New Drug...

 
 
 

VIKING THERAPEUTICS ANNOUNCES DATA FROM IN VIVO STUDY OF VK2809 PRESENTED AT ORAL PLENARY SESSION OF THE 88TH ANNUAL MEETING OF AMERICAN THYROID ASSOCIATION

VK2809 Treatment Leads to Rapid Reduction in Steatosis, Inflammation and Liver Size in Mouse Model of Glycogen Storage Disease Type...

 
 
 
New VARI Initiative Aims to Understand How Metabolism Drives Disease

NEW VARI INITIATIVE AIMS TO UNDERSTAND HOW METABOLISM DRIVES DISEASE

Back in the 1990s, dietary fat was considered “Enemy Number One.” In the late '80s, new research had found that a diet high in saturated...

JOERNS HEALTHCARE LAUNCHES FULL SUITE OF NEW PRODUCTS AT AHCA 2018

SAN DIEGO, Oct. 7, 2018 /PRNewswire/ - Joerns Healthcare is excited to debut two new bed systems at AHCA 2018. The new suite of products...

 
 
 

DIRECTOR, HUMAN RESOURCES BUSINESS PARTNER - ACADIA PHARMACEUTICALS INC. - SAN DIEGO, CA

Familiarity with benefit program design and delivery. Provides expert advice and counsel to assigned group leaders on organization...

 
 
 
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant's IPO & More

BIO ROUNDUP: NOBEL PRIZES, DUCHENNE STEPS, GUARDANT'S IPO & MORE

Cancer immunotherapy is all the rage these days. The idea of harnessing the immune system to treat cancer has sparked billions of dollars...

FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom

FDA APPROVES ROCHE DRUG FOR ALL HEMOPHILIA A PATIENTS, BUT RIVALS LOOM

The treatment landscape for hemophilia is changing fast, and today marks a turning point. The FDA has just cleared Roche to sell its...

 
 
 
Paratek Pharma Wins Two FDA Approvals for Three Conditions in Same Day

PARATEK PHARMA WINS TWO FDA APPROVALS FOR THREE CONDITIONS IN SAME DAY

The FDA has approved a Paratek Pharmaceuticals antibiotic as a treatment for pneumonia and serious skin infections. The FDA decision...

Elemental Lands Partnership With PerkinElmer, Plus $9M in VC Bucks

ELEMENTAL LANDS PARTNERSHIP WITH PERKINELMER, PLUS $9M IN VC BUCKS

Elemental Machines is a startup making progress in a challenging field. That field would be sensors and systems that monitor and optimize...